Global CRO Services

Many global CROs scale by layering regions onto disconnected systems. Precision was built to operate globally from the start, aligning clinical operations, translational science, and regulatory strategy within a single execution model. This integration reduces handoffs, limits regional fragmentation, and keeps global programs aligned from early planning through submission.

Precision combines centralized program oversight with experienced regional teams across North America, Europe, Latin America, and Asia‑Pacific. Global standards govern execution and data quality, while local experts adapt to regional regulatory, operational, and site‑level realities to keep trials moving without compromising consistency.

Precision supports coordinated global regulatory strategies across FDA, EMA, and international health authorities. Regulatory planning begins early, aligning pre‑IND or CTA activities with downstream submission goals so that regional requirements, timelines, and data expectations remain synchronized throughout development.

Biomarker and translational insights are directly connected to clinical trial design, patient selection, and endpoint strategy. This approach strengthens early decision‑making and ensures that biological insights are carried cleanly through global execution, regulatory submissions, and commercialization planning.

Global execution is especially critical for programs in oncology, rare and orphan diseases, and advanced modalities where patient populations are limited and regulatory complexity is high. Sponsors running multi‑region trials or planning for global submission benefit most from an integrated CRO model that reduces operational and regulatory risk.

Yes. Sponsors can engage Precision as a full‑service global CRO or through FSP models that embed functional experts within sponsor teams. Both models operate within the same global infrastructure and quality framework, allowing flexibility without sacrificing oversight or execution standards.